The UCP2-866 A/A genotype is associated with low density lipoprotein particle sizes in the general population

Medical Science Monitor

Volumn 14, Issue 3, 2008, Pages

  Hamada, Taku ^a   Kotani, Kazuhiko ^a,b   Fujiwara, Shinji ^c,d   Sano, Yoshiko ^a   Domichi, Masayuki ^a   Tsuzaki, Kokoro ^a   Takahashi, Kaoru ^e   Sakane, Naoki ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d Mima City National Health Insurance Koyadaira Clinic   (Japan)

^e KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

LDL particle size; Lipid; Polymorphism; Small dense LDL; UCP2

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; UNCOUPLING PROTEIN 2;

ADULT; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; DNA DETERMINATION; FEMALE; FLUORESCENCE ANALYSIS; GENE FREQUENCY; GENOTYPE; HUMAN; JAPANESE; MALE; MULTIPLE REGRESSION; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POPULATION GENETICS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BODY MASS INDEX; FEMALE; GENOTYPE; HUMANS; ION CHANNELS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; PARTICLE SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 41449091893     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Dalgaard LT, Hansen T, Urhammer SA et al: The uncoupling protein 3-55 C>T variant is not associated with Type II diabetes mellitus in Danish subjects. Diabetologia, 2001; 44: 1065-67
2. Saleh MC, Wheeler MB, Chan CB: Uncoupling protein-2: evidence for its function as a metabolic regulator. Diabetologia, 2002; 45: 174-87
3. Hesselink MK, Mensink M, Schrauwen P: Human uncoupling protein-3 and obesity: an update. Obes Res, 2003; 11: 1429-43
4. Fleury C, Neverova M, Collins S et al: Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet, 1997; 15: 269-72
5. Argyropoulos G, Brown AM, Peterson R et al: Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects. Diabetes, 1998; 47: 685-87
6. Argyropoulos G, Harper ME: Uncoupling proteins and thermoregulation. J Appl Physiol, 2002; 92: 2187-98
7. Arsenijevic D, Onuma H, Pecqueur C et al: Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet, 2000; 26: 435-39
8. Blanc J, Alves-Guerra MC, Esposito B et al: Protective role of uncoupling protein 2 in atherosclerosis. Circulation, 2003; 107: 388-90
9. Esterbauer H, Schneitler C, Oberkofler H et al: A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet, 2001; 28: 178-83
10. Krempler F, Esterbauer H, Weitgasser R et al: A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes, 2002; 51: 3331-35
11. Wang H, Chu WS, Lu T et al: Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am J Physiol Endocrinol Metab, 2004; 286: E1-7
12. Sasahara M, Nishi M, Kawashima H et al: Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients. Diabetes, 2004; 53: 482-85
13. Bulotta A, Ludovico O, Coco A et al: The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy. J Clin Endocrinol Metab, 2005; 90: 1176-80
14. Yamasaki H, Sasaki H, Ogawa K et al: Uncoupling protein 2 promoter polymorphism -866G/A affects peripheral nerve dysfunction in Japanese type 2 diabetic patients. Diabetes Care, 2006; 29: 888-94
15. Ji Q, Ikegami H, Fujisawa T et al: A common polymorphism of uncoupling protein 2 gene is associated with hypertension. J Hypertens, 2004; 22: 97-102
16. Oberkofler H, Iglseder B, Klein K et al: Associations of the UCP2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol, 2005; 25: 604-10
17. Cho HK, Shin G, Ryu SK et al: Regulation of small dense LDL concentration in Korean and Scottish men and women. Atherosclerosis, 2002; 164: 187-93
18. Gardner CD, Fortmann SP, Krauss RM: Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA, 1996; 276: 875-81
19. Lamarche B, Tchernof A, Moorjani S et al: Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation, 1997; 95: 69-75
20. Austin MA, Mykkanen L, Kuusisto J et al: Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation, 1995; 92: 1770-78
21. Hoefner DM, Hodel SD, O'Brien JF et al: Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem, 2001; 47: 266-74
22. Yamada Y, Izawa H, Ichihara S et al: Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med, 2002; 347: 1916-23
23. Gardner CD, Fortmann SP, Krauss RM: Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA, 1996; 276: 875-81
24. Arad Y, Rumsey SC, Galeano NF et al: LDL has optimal size for maximal binding to the LDL receptor. Circulation, 1992; 86: I-551
25. Tribble DL, Holl LG, Wood PD et al: Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis, 1992; 93: 189-99
26. Toshima S, Hasegawa A, Kurabayashi M et al: Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol, 2000; 20: 2243-47
27. Ehara S, Ueda M, Naruko T et al.: Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 2001, 17(103): 1955-60
28. Mauger JF, Lichtenstein AH, Ausman LM et al: Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr, 2003; 78: 370-75
29. Bosse Y, Chagnon YC, Despres JP et al: Compendium of genome-wide scans of lipid-related phenotypes: adding a new genome-wide search of apolipoprotein levels. J Lipid Res, 2004; 45: 2174-84
30. Negre-Salvayre A, Hirtz C, Carrera G et al: A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J, 1997; 11: 809-15
31. Cannon B, Shabalina IG, Kramarova TV et al: Uncoupling proteins: a role in protection against reactive oxygen species - or not? Biochim Biophys Acta, 2006; 1757: 449-58
32. Ryu JW, Hong KH, Maeng JH et al: Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration. Arterioscler Thromb Vasc Biol, 2004; 24: 864-70
33. Duval C, Negre-Salvayre A, Dogilo A et al: Increased reactive oxygen species production with antisense oligonucleotides directed against uncoupling protein 2 in murine endothelial cells. Biochem Cell Biol, 2002; 80: 757-64
34. Dhamrait SS, Stephens JW, Cooper JA et al: Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. Eur Heart J, 2004; 25: 468-75
35. Sesti G, Cardellini M, Marini MA et al: A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes, 2003; 52: 1280-83
36. Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C et al: A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetes. Mol Genet Metab, 2004; 82: 339-44
37. Cha MH, Kim IC, Kim KS et al: Association of UCP2 and UCP3 gene polymorphisms with serum high-density lipoprotein cholesterol among Korean women. Metabolism, 2007; 56: 806-13